Research & Scholarship
Cost-effectiveness analysis, pharmacoeconomics, utility assessment and health-related quality of life (HRQL)
Slejko JF, Sullivan PW, Anderson HD, Ho PM, Nair KV, Campbell JD. (2014). Dynamic medication adherence modeling in primary prevention of cardiovascular disease: a markov microsimulation methods application. Value Health. (6):725-31. DOI: 10.1016/j.jval.2014.06.010. Epub 2014 Jul 28. http://www.ncbi.nlm.nih.gov/pubmed/25236996
Slejko, J. F., Ho, M., Anderson, H. D., Nair, K. V., Sullivan, P. W., & Campbell, J. D. (2014). Adherence to statins in primary prevention: yearly adherence changes and outcomes. Journal of Managed Care Pharmacy: JMCP, 20(1), 51–57.
Sullivan, P. W., Slejko, J. F., Ghushchyan, V. H., Sucher, B., Globe, D. R., Lin, S.-L., & Globe, G. (2014). The relationship between asthma, asthma control and economic outcomes in the United States. The Journal of Asthma: Official Journal of the Association for the Care of Asthma, doi: 10.3109/02770903.2014.906607.
Sullivan, P. W., Smith, K. L., Ghushchyan, V. H., Globe, D. R., Lin, S.-L., & Globe, G. (2013). Asthma in USA: its impact on health-related quality of life. The Journal of Asthma: Official Journal of the Association for the Care of Asthma, 50(8), 891–899. doi:10.3109/02770903.2013.813035
tcomes in the United States. The Journal of Asthma: Official Journal of the Association for the Care of Asthma, doi: 10.3109/02770903.2014.906607.
Slejko, J. F., Ghushchyan, V. H., Sucher, B., Globe, D. R., Lin, S.-L., Globe, G., & Sullivan, P. W. (2013). Asthma control in the United States, 2008-2010: Indicators of poor asthma control. The Journal Of Allergy And Clinical Immunology.
Sullivan, P.W., Ghushchyan, V., Bayliss, E. (2012). The impact of comorbidity burden on preference-based HRQL in the United States. Pharmacoeconomics, 30(5), 431–42.
McQueen RB, Ellis SL, Campbell JD, Nair KV, Sullivan PW2. Cost-Effectiveness of Continuous Glucose Monitoring and Intensive Insulin Therapy for Type 1 Diabetes. Cost Effectiveness and Resource Allocation. 2011, 9:13.
Padula WV, Sullivan PW2, Beyond migraines: how healthy are the 2012 presidential contenders? The Atlantic. August 3, 2011. http://www.theatlantic.com/politics/archive/2011/08/beyond-migraines-how-healthy-are-the-2012-presidential-contenders/242494/
Sullivan PW1. Are Utilities Bounded at 1.0? Implications for Statistical Analysis and Scale Development. Medical Decision Making. Mar 21 2011.
Sullivan PW1, Slejko MF, Sculpher MJ, Ghushchyan V. Catalogue of EQ-5D Scores for the United Kingdom. Medical Decision Making. 2011 Dec; 31(6):800-804.
Padula WV, Mishra MK, Makic MBF, Sullivan PW2. Improving the quality of pressure ulcer care with prevention: a cost-effectiveness analysis. Medical Care. 2011 Apr;49(4):385-392.
Sullivan PW1, Ghushchyan V, Bayliss E. The impact of comorbidity burden on preference-based HRQL in the United States. Pharmacoeconomics. 2011. In Press.
Sullivan PW1, Ghushchyan V, Slejko J, Belozeroff V, Globe D, Lin S. The burden of adult asthma in the United States: evidence from the Medical Expenditure Panel Survey. Journal of Allergy and Clinical Immunology. 2011 Feb;127(2):363-369.
Slejko JF, Page RL 2nd, Sullivan PW2. Cost-effectiveness of statin therapy for vascular event prevention in adults with elevated C-reactive protein: implications of JUPITER. Current Medical Research and Opinion. 2010 Oct;26(10):2485-97.
Sullivan PW1, Navaratnam P, Lorber, R, Shakar T. The cost-effectiveness of treatment with desloratadine in patients with persistent allergic rhinitis. Current Medical Research and Opinion. 2010 Jun;26(6):1389-97.
Sullivan PW1, Ghushchyan V, Huang XY, Globe DR. Influence of rheumatoid arthritis on employment, function, and productivity in a nationally representative sample in the United States. J Rheumatol. 2010 Mar;37(3):544-9.Recent Presentations
Sullivan PW. The Severe Asthma Population In The United States: Claims-Based Analysis Of Outcomes In Global Initiative For Asthma (Gina) Steps 4/5. ISPOR 19th Annual International Meeting. June 3, 2014.
Sullivan, PW, Campbell, JD, Ghushchyan, V., Globe, G., Magid, D., Bender, B., Woolley, M. Differences In Sensitivity To Asthma Control Between Generic And Asthma-Specific Health-Related Quality Of Life Instruments. American Thoracic Society (ATS) International Conference, San Diego, CA, May 19, 2014.
Sullivan PW, Campbell JD, Ghushchyan V, Globe G, Lange J,Woolley M. “Characterizing the Severe Asthma Population in the United States: Claims-based Analysis of Three Treatment Cohorts in the Year Prior to Treatment Escalation.” American Association of Asthma Allergy and Inflammation (AAAAI) San Diego, CA, March 1, 2014.
Sullivan, P. Identifying high risk or high value patient cohorts: Overview of methods and applications of patient phenotyping analyses. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual International Meeting, New Orleans, LA. Platform. May 20, 2013.
Sullivan, P.W. (2013). Poor Asthma Control Results in Decreased Productivity and More Exacerbations. AAAAI Annual Meeting. San Antonio, TX.
Ghushchyan, V.H., Sullivan, P.W. (May 1, 2011) Expected changes in health care utilization due to patient protection and affordable care act, International Society for Pharmacoeconomics and Outcomes Research, Baltimore, MD.
"Reducing the Burden of Persistent Allergic Rhinitis". Antihistamine Summit. Vienna, Austria. February 4-6, 2010.
Peer-reviewed Podium Presentations:
Sullivan, P. Poor asthma control is associated with decreased HRQOL. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual International Meeting, New Orleans, LA. Poster. May 20, 2013.
Slejko J, Sullivan PW, Page R, Nair K, Campbell J. "Modeling medication adherence behavior in cost-effectiveness analysis: the jupiter example". Society for Medical Decision Making. October 2011. Chicago, IL.
"Using A Catalogue Of EQ-5D Scores To Model QALYs For Cost-Effectiveness Analyses." ISPOR. Atlanta, GA. May 18 2010.
"Incorporating Tariff-Level Uncertainty Around Estimates From The Catalogue Of EQ-5D Scores." ISPOR. Atlanta, GA. May 18 2010.
"Comparison Of Health State Utility Estimates In Cost-Effectiveness Analysis" (Julia Slejko PhD advisee). ISPOR. Atlanta, GA. May 18 2010.
"Under Pressure--Reducing Hospital-acquired Pressure Ulcer Rates with Prevention: A Cost-effectiveness Analysis" (Bill Padulla, PhD advisee) 21st Annual Rocky Mountain Regional Multidisciplinary Research & Evidence-Based Practice Symposium. Denver, CO March 5 2010.
Sullivan PW, Fraessdorf M, Feuring M, Schulman S, Hass B. Health-related quality of life after venous thromboembolism. ISPOR. Madrid, Spain. November 2011.
Sullivan PW, Ghushchyan VH. Can utilities exceed 1.0? Empirical evidence of the ceiling effect. ISPOR. Baltimore, MD. May 2011.
Ghushchyan VH, Sullivan PW. Expected changes in health care utilization due to patient protection and affordable care act. ISPOR. Baltimore, MD. May 2011.
Peter Clapp, Matthew G. Fete, Patrick Sullivan, Marianne McCollum, Jason Brunner, and Charlotte Ricchetti. A New Tool for Peer Assessment in Team Based Learning. Team-Based Learning in Higher Education. Las Vegas, NV. March 2011.
Jason M. Brunner, Marianne McCollum, Peter Clapp, Matthew Fete, Patrick Sullivan, Charlotte Ricchetti. The Assessment of a Multi-method Peer Evaluation Tool. Team-Based Learning in Higher Education. Las Vegas, NV. March 2011.
Sullivan PW, Ghushchyan V, Slejko J, Belozeroff V, Globe D, Lin S. The burden of adult asthma in the United States: evidence from the Medical Expenditure Panel Survey. Amgen Observational Research Conference. October 2010.
Slejko J, Page R, Sullivan PW. Statin therapy is cost-effective for vascular event prevention in adults with elevated c-reactive protein: implications of JUPITER. American College of Cardiology. Atlanta, GA. March 15, 2010.